Symbicort Turbuhaler 30/60 Specific Clinical Experience Investigation (ENSURE)

AstraZeneca

Status: Completed

Conditions: Bronchial Asthma

Study type: Observational

Funder types: Industry

Identifiers

NCT01232335

D589IC00001

Details and patient eligibility

About

The purpose of this study is to confirm the safety profile for long term treatment and maximize doses and the control status on bronchial asthma in daily clinical usage

Enrollment: 1,500 patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients treated with Symbicort for the first time possibly at the higher dose due to bronchial asthma

Exclusion criteria